Science

The new variant may undermine some vaccine-derived defenses. But the immune system’s best assassins are likely to hold the line.By Katherine...

 View ORCID ProfileAlexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared G. Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug, Deborah H. Fuller, Frederick A. Matsen IV, Julie Overbaugh Abstract Macaques are a commonly used...

January 27, 2021 at 8:30 AM EST A computational simulation model showed that a norovirus vaccine costing as much as $1,300 can...

February 3, 2021 at 8:30 AM ESTPDF Version Study reached primary and secondary endpoints of safety and immunogenicity, respectivelyVXA-CoV2-1 induced...

October 26, 2021 at 8:00 AM EDT Vaxart expects to enroll 96 subjects at four sites in the United States in the first...

Marios Koutsakos, Patricia T. Illing, …Katherine Kedzierska Abstract Influenza A, B and C viruses (IAV, IBV and ICV, respectively) circulate globally and...

Authored byStaffUpdated December 1, 2021 Last reviewed December 1, 2021 Fact checked byRobert Carlson, MD + Holly Lutmer PharmDShare Vaxart COVID-19 Oral...

4 February 2021 A preliminary analysis shows VXA-CoV2-1 was well-tolerated and induced T-cell and IgA responses against SARS-CoV-2 antigens in...

November 18, 2021 at 4:02 PM ESTPDF Version A new Stanford study published in Cell Host and Microbe finds that...

Abstract Transmission-blocking strategies that slow the spread of SARS-CoV-2 and protect against COVID-19 are needed. We have developed a shelf-stable,...

Samir Andrade Mendonça, Reka Lorincz, Paul Boucher & David T. Curiel  npj Vaccines volume 6, Article number: 97 (2021) Cite this article 20k Accesses6 Citations67 AltmetricMetricsdetails Abstract Adenoviral vectors have been explored as...